{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "In vivo methods of treatment to prevent kidney dysfunction using substances that inhibit albumin glycation", "item": "https://www.patentleaderboard.com/patent/6001875"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › In vivo methods of treatment to prevent kidney dysfunction using substances that inhibit albumin glycation

In vivo methods of treatment to prevent kidney dysfunction using substances that inhibit albumin glycation

US Patent 6001875 · Granted Dec 14, 1999

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] ph2015
Albumin-binding compounds that prevent nonenzymatic glycation and that may be us2003
Albumin-binding compounds that prevent nonenzymatic glycation and that may be us2002
In Vivo Methods to reduce hypercholesterolemia and improve vascular dysfunction1999
In Vivo Methods to reduce hypercholesterolemia and improve vascular dysfunction1999
Genetically engineered immunoglobulins with specificity for glycated albumin1999
Treatment of complications of diabetes with substances reactive with the fructos1996
Monoclonal antibodies against glycated low density lipoprotein1996
Isolation of a soluble 42 KD pancreatic islet cell autoantigen1994
Monoclonal antibodies against glycated albumin, hybrid cell lines producing thes1993
Monoclonal antibodies specific for non-A1C glycated hemoglobin and immunoassay m1993